Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

RARERARE
Showing 8 of 15 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in ULTRAGENYX PHARMACEUTICAL IN

WELLINGTON MANAGEMENT GROUP LLP holds 1.3M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $41.8M as of 2026-Q2. The position was decreased (-52.6% shares). RARE represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$41.8M

Current Shares

1.3M

Total Value Change

-$189.6M

Total Shares Change

-2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.3M
-52.6%
$41.8M0.0%$33.39
0
2026-Q1
Increased
2.6M
+7.3%
$55.3M0.0%$22.07
32
2025-Q4
Increased
2.5M
+26.6%
$56.6M0.0%$22.78
36
2025-Q3
Increased
1.9M
+3.9%
$58.5M0.0%$30.36
31
2025-Q2
Decreased
1.9M
-23.6%
$68.1M0.0%$36.52
0
2025-Q1
Decreased
2.4M
-0.3%
$88.7M0.0%$37.82
0
2024-Q4
Decreased
2.5M
-41.0%
$103.4M0.0%$42.27
0
2024-Q3
Decreased
4.2M
-8.6%
$231.4M0.0%$54.43
0

Other major holders of RARE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used